GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
GSK is to move more than 1,000 of its scientists to its new Cambridge research and development centre. Illustration: GSKView image in fullscreenGSK is to move more than 1,000 of its scientists to its new Cambridge research and development centre. It will close its R&D site in Stevenage in Hertfordshire by 2029, while upgrading its R&D laboratories at nearby Ware and moving some employees there.Luke Miels, the GSK chief executive, said: “This investment will accelerate our R&D and help us deliver new, competitive products.
- ▪GSK is to move more than 1,000 of its scientists to its new Cambridge research and development centre.
- ▪Illustration: GSKView image in fullscreenGSK is to move more than 1,000 of its scientists to its new Cambridge research and development centre.
- ▪It will close its R&D site in Stevenage in Hertfordshire by 2029, while upgrading its R&D laboratories at nearby Ware and moving some employees there.Luke Miels, the GSK chief executive, said: “This investment will accelerate our R&D and he
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 2,284 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | the Guardian |
| Canonical URL | https://www.theguardian.com/business/2026/jul/28/gsk-cut-jobs-cost-cutting-faster-drug-development-cambridge |
| Publication time | Tue, 28 Jul 2026 13:20:22 GMT |
| Retrieval time | 2026-07-28T13:33:28.055Z |
| Last seen | 2026-07-28T13:33:28.055Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 6umwkuY5uzy7 · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
GSK is to move more than 1,000 of its scientists to its new Cambridge research and development centre. Illustration: GSKView image in fullscreenGSK is to move more than 1,000 of its scientists to its new Cambridge research and development centre. Illustration: GSKPharmaceuticals industryGSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug developmentPharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site Business live – latest updates Joanna PartridgeTue 28 Jul 2026 09.20 EDTLast modified on Tue 28 Jul 2026 09.29 EDTSharePrefer the Guardian on GoogleThe British drugmaker GSK is to announce sweeping job cuts as part of a £1.9bn cost-cutting programme to pay for a £400m investment in UK life sciences over the next three…
Excerpt limited to ~120 words for fair-use compliance. The full article is at the Guardian.
Discussion
0 commentsMore from the Guardian
